As in the cathepsin B knockout data, cathepsin B inhibitors reduced brain Aβ(1-40/42) and pGlu Aβ(3-40/42) in transgenic AD mice expressing human APP containing the wt β-secretase site but not in those expressing the Swe mutant β-secretase site (141, 256). This evidence concerns the gene APP and Alzheimer disease.